About Careers Internship MedBlog Contact us

Uganda Opens Factory to Manufacture Generic AIDS Drug

by Medindia Content Team on October 9, 2007 at 8:05 PM
Uganda Opens Factory to Manufacture Generic AIDS Drug

Uganda on Monday opened a 38-million-dollar (27-million-euro) plant that will manufacture generic versions of AIDS drugs for domestic and export markets.

The Kampala-based Quality Chemicals Limited, which was launched by President Yoweri Museveni, will start producing antiretrovirals (ARVs) in January with help and ingredients from Indian giant drugmaker Cipla.


The firm will also manufacture artemisinin combination (ACTs), a therapy that treats malaria, the largest killer in the east African nation of 27 million.

"The government commits itself to its promise of purchasing the ARVs for AIDS patients and ACTs for malaria from the factory for hospitals," Museveni said at the launch ceremony.

Of the country's 250,000 patients in need of the life-prolonging drugs, only 80,000 have had access, according to official figures.

"The project offers Uganda a regular and cheap supply of medication," said Emmanuel Katongole, the company chief.

Starting January, the pharma will be making two million tablets per day -- 600 million tablets a year -- with an ambition of increasing to 1.2 billion tablets a year.

Extra ARVs will be exported to Kenya, Tanzania, Democratic Republic of Congo and Sudan.

AIDS has killed at least one million Ugandans since it was first diagnosed some 24 years ago, while a similar number carry the virus that causes the disease.

The country has managed to scale down its infection rates from as high as 30 percent in early 1990s to about 6 percent currently.

Uganda joins Egypt, Nigeria and South Africa as the only African nations with firms that produce generics. Mozambique plans to take the same direction.

At the end of 2005, around 40 million people lived with AIDS or HIV, nearly two-thirds of them south of the Sahara, according to UN figures.

Source: AFP
Font : A-A+



Recommended Readings

Latest Drug News

Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Uganda Opens Factory to Manufacture Generic AIDS Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests